 on March 22, 2017.95
c
Now Terumo.
b

grafting of the thoracic aorta is technically feasible and
nonrandomized studies suggest reduction of early
adverse outcomes, such as paraplegia, mortality, and
hospital stay, high-quality randomized controlled trials
assessing clinically relevant outcomes including open
conversion, aneurysm exclusion, endoleaks, and late
mortality are needed.8